Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity

被引：49

作者：

Bol, Kalijn F. ^{[1
,2
]}

Aarntzen, Erik H. J. G. ^{[1
,2
,5
]}

Pots, Jeanette M. ^{[1
]}

Nordkamp, Michel A. M. Olde ^{[1
]}

van de Rakt, Mandy W. M. M. ^{[1
]}

Scharenborg, Nicole M. ^{[1
]}

de Boer, Annemiek J. ^{[1
]}

van Oorschot, Tom G. M. ^{[1
]}

Croockewit, Sandra A. J. ^{[3
]}

Blokx, Willeke A. M. ^{[4
]}

Oyen, Wim J. G. ^{[5
]}

Boerman, Otto C. ^{[5
]}

Mus, Roel D. M. ^{[5
]}

van Rossum, Michelle M. ^{[6
]}

van der Graaf, Chantal A. A. ^{[7
]}

Punt, Cornelis J. A. ^{[8
]}

Adema, Gosse J. ^{[1
]}

Figdor, Carl G. ^{[1
]}

de Vries, I. Jolanda M. ^{[1
,2
]}

Schreibelt, Gerty ^{[1
]}

机构：

[1] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Tumor Immunol, POB 9101, NL-6500 HB Nijmegen, Netherlands

[2] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6525 ED Nijmegen, Netherlands

[3] Radboud Univ Nijmegen, Med Ctr, Dept Hematol, NL-6525 ED Nijmegen, Netherlands

[4] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands

[5] Radboud Univ Nijmegen, Med Ctr, Dept Radiol & Nucl Med, NL-6525 ED Nijmegen, Netherlands

[6] Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, NL-6525 ED Nijmegen, Netherlands

[7] Radboud Univ Nijmegen, Med Ctr, Dept Pulm Dis, NL-6525 ED Nijmegen, Netherlands

[8] Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands

来源：

CANCER IMMUNOLOGY IMMUNOTHERAPY | 2016年 / 65卷 / 03期

基金：

欧洲研究理事会;

关键词：

Dendritic cells; Immunotherapy; Melanoma; Toll-like receptor ligands; Maturation; Prophylactic vaccines; T-CELLS; MESSENGER-RNA; STAGE-III; IMMUNE-RESPONSES; VACCINATION; IMMUNOTHERAPY; INDUCTION; PEPTIDE; CD4(+); CANCER;

D O I：

10.1007/s00262-016-1796-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Dendritic cell (DC)-based immunotherapy is explored worldwide in cancer patients, predominantly with DC matured with pro-inflammatory cytokines and prostaglandin E-2. We studied the safety and efficacy of vaccination with monocyte-derived DC matured with a cocktail of prophylactic vaccines that contain clinical-grade Toll-like receptor ligands (BCG, Typhim, Act-HIB) and prostaglandin E-2 (VAC-DC). Stage III and IV melanoma patients were vaccinated via intranodal injection (12 patients) or combined intradermal/intravenous injection (16 patients) with VAC-DC loaded with keyhole limpet hemocyanin (KLH) and mRNA encoding tumor antigens gp100 and tyrosinase. Tumor antigen-specific T cell responses were monitored in blood and skin-test infiltrating-lymphocyte cultures. Almost all patients mounted prophylactic vaccine- or KLH-specific immune responses. Both after intranodal injection and after intradermal/intravenous injection, tumor antigen-specific immune responses were detected, which coincide with longer overall survival in stage IV melanoma patients. VAC-DC induce local and systemic CTC grade 2 and 3 toxicity, which is most likely caused by BCG in the maturation cocktail. The side effects were self-limiting or resolved upon a short period of systemic steroid therapy. We conclude that VAC-DC can induce functional tumor-specific responses. Unfortunately, toxicity observed after vaccination precludes the general application of VAC-DC, since in DC maturated with prophylactic vaccines BCG appears to be essential in the maturation cocktail.

引用

页码：327 / 339

页数：13

共 33 条

[1] Targeting of 111In-Labeled Dendritic Cell Human Vaccines Improved by Reducing Number of Cells
Aarntzen, Erik H. J. G.
Srinivas, Mangala
Bonetto, Fernando
Cruz, Luis J.
Verdijk, Pauline
Schreibelt, Gerty
van de Rakt, Mandy
Lesterhuis, W. Joost
van Riel, Maichel
Punt, Cornelius J. A.
Adema, Gosse J.
Heerschap, Arend
Figdor, Carl G.
Oyen, Wim J.
de Vries, I. Jolanda M.
[J]. CLINICAL CANCER RESEARCH, 2013, 19 (06) : 1525 - 1533
[2] Targeting CD4+ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell-Based Vaccination
Aarntzen, Erik H. J. G.
De Vries, I. Jolanda M.
Lesterhuis, W. Joost
Schuurhuis, Danita
Jacobs, Joannes F. M.
Bol, Kalijn
Schreibelt, Gerty
Mus, Roel
De Wilt, Johannes H. W.
Haanen, John B. A. G.
Schadendorf, Dirk
Croockewit, Alexandra
Blokx, Willeke A. M.
Van Rossum, Michelle M.
Kwok, William W.
Adema, Gosse J.
Punt, Cornelis J. A.
Figdor, Carl G.
[J]. CANCER RESEARCH, 2013, 73 (01) : 19 - 29
[3] Skin-Test Infiltrating Lymphocytes Early Predict Clinical Outcome of Dendritic Cell-Based Vaccination in Metastatic Melanoma
Aarntzen, Erik H. J. G.
Bol, Kalijn
Schreibelt, Gerty
Jacobs, Joannes F. M.
Lesterhuis, W. Joost
Van Rossum, Michelle M.
Adema, Gosse J.
Figdor, Carl G.
Punt, Cornelis J. A.
De Vries, I. Jolanda M.
[J]. CANCER RESEARCH, 2012, 72 (23) : 6102 - 6110
[4] Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4+ and CD8+ T Cells Responses in Stage III and IV Melanoma Patients
Aarntzen, Erik H. J. G.
Schreibelt, Gerty
Bol, Kalijn
Lesterhuis, W. Joost
Croockewit, Alexandra J.
de Wilt, Johannes H. W.
van Rossum, Michelle M.
Blokx, Willeke A. M.
Jacobs, Joannes F. M.
Duiveman-de Boer, Tjitske
Schuurhuis, Danita H.
Mus, Roel
Thielemans, Kris
de Vries, I. Jolanda M.
Figdor, Carl G.
Punt, Cornelis J. A.
Adema, Gosse J.
[J]. CLINICAL CANCER RESEARCH, 2012, 18 (19) : 5460 - 5470
[5] Humoral anti-KLH responses in cancer patients treated with dendritic cell-based immunotherapy are dictated by different vaccination parameters
Aarntzen, Erik H. J. G.
de Vries, I. Jolanda M.
Goertz, Joop H.
Beldhuis-Valkis, Marjo
Brouwers, Huberdina M. L. M.
van de Rakt, Mandy W. M. M.
van der Molen, Renate G.
Punt, Cornelis J. A.
Adema, Gosse J.
Tacken, Paul J.
Joosten, Irma
Jacobs, Joannes F. M.
[J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (11) : 2003 - 2011
[6] Toll-like receptor signalling
Akira, S
Takeda, K
[J]. NATURE REVIEWS IMMUNOLOGY, 2004, 4 (07) : 499 - 511
[7] Molecular Confirmation of Bacillus Calmette Guerin Vaccine Related Adverse Events among Saudi Arabian Children
Al-Hajoj, Sahal
Memish, Ziad
Abuljadayel, Naila
AlHakeem, Raafat
AlRabiah, Fahad
Varghese, Bright
[J]. PLOS ONE, 2014, 9 (11):
[8] Dendritic cells and the control of immunity
Banchereau, J
Steinman, RM
[J]. NATURE, 1998, 392 (6673) : 245 - 252
[9] Efficient elutriation of monocytes within a closed system (Elutra™) for clinical-scale generation of dendritic cells
Berger, TG
Strasser, E
Smith, R
Carste, C
Schuler-Thurner, B
Kaempgen, E
Schuler, G
[J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2005, 298 (1-2) : 61 - 72
[10] Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients
Bol, Kalijn F.
Figdor, Carl G.
Aarntzen, Erik H. J. G.
Welzen, Marieke E. B.
van Rossum, Michelle M.
Blokx, Willeke A. M.
van de Rakt, Mandy W. M. M.
Scharenborg, Nicole M.
de Boer, Annemiek J.
Pots, Jeanette M.
Nordkamp, Michel A. M. Olde
van Oorschot, Tom G. M.
Mus, Roel D. M.
Croockewit, Sandra A. J.
Jacobs, Joannes F. M.
Schuler, Gerold
Neyns, Bart
Austyn, Jonathan M.
Punt, Cornelis J. A.
Schreibelt, Gerty
de Vries, I. Jolanda M.
[J]. ONCOIMMUNOLOGY, 2015, 4 (08):

← 1 2 3 4 →